The current study, which examined how 3-hydroxy-β-ionone (3-HBI) affects HSC liver fibrosis in vitro, found that these fibrosis-associated genes were upregulated in HSCs following the activation of the TGF-β/SMAD signaling pathway. The gene discussed is TGFB1; the disease is fibrosis.